An amendment to an offering — the company changed its terms or corrected its filing.

AlphaRose Therapeutics Inc

AlphaRose Therapeutics Inc filed a Form C/A — amendment — with the SEC on Aug 14, 2025. The Regulation Crowdfunding offering seeks $19,999, up to a maximum of $4,999,999 on StartEngine. Investors receive: Common Stock at $1.35. The offering closes 08-28-2025.

The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.